The effect of suppressive thyroxine therapy in nodular goiter in postmenopausal women and 2 year's bone mineral density change.

In conclusion, thyroxine suppressive therapy in postmenopausal women had significant reduction in nodule volume at initial 2 years of treatment, especially in volume larger than 2.6 mL. Prolonged thyroxine treatment did not benefit nodular size reduction and may affect BMD minimally in postmenopausal women. PMID: 30158361 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30158361?dopt=Abstract

Source: Endocrine Journal - August 31, 2018 Category: Endocrinology Tags: Endocr J Source Type: research

More News: Endocrinology | Study | Women